SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

DOUBLE-CHOICE: Lower Pacemaker Implantation Rates with ACURATE neo2 Compared with Evolut in Patients Undergoing TAVI

Dr. Andrés Rodríguez - 1 June, 2026 0

The DOUBLE-CHOICE trial is a multicenter, randomized, controlled study conducted in Germany to evaluate the performance of next-generation transcatheter heart valves and different anesthesia...

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Dr. Andrés Rodríguez - 29 May, 2026 0

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Dr. Juan Manuel Pérez - 26 May, 2026 0

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

Noticias Institucionales

Open Session | Current Endovascular Treatment of Tricuspid Regurgitation

solaci - 1 June, 2026 0

SOLACI and the Argentine College of Interventional Cardioangiologists (CACI) invite you to participate in a new Open Session of the Advanced Postgraduate Course in...

06/03 | SOLACI Technicians & Nurses Webinar – Clinical Impact of Structural Interventions: TAVI and MitraClip in Current Practice

solaci - 28 May, 2026 0

The Latin American Society of Interventional Cardiology (SOLACI), through its Technicians and Nurses Department, invites you to participate in a new scientific webinar entitled...

SOLACI Presented an Outstanding Scientific Session on Complex Coronary Lesions at EuroPCR 2026

solaci - 22 May, 2026 0

The Latin American Society of Interventional Cardiology (SOLACI) had a prominent participation at EuroPCR 2026 through an institutional scientific session held on May 21...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad

Tag: DES

EuroPCR 2021 | Ultrathin Struts Consolidate as Next DES Development

Short Therapy and Monotherapy, Plenty of Evidence

Biodegradable Polymer Myth Also Debunked for ACSs

Last Bastion of Bare Metal Stents Finally Falls

Current DES Performance: Is There Room for Improvement?

In-Stent Restenosis Treatment: Meta-Analysis of 10 Randomized Studies

TCT 2020 | The Myth of Biodegradable Polymers Seems to Have...

ISAR-TEST-5: 10 años de los DES con polímero vs sin polímero

Two-Stent Strategy is Safer in True Bifurcation Lesions

Onyx ONE: More Options for Patients at High Risk for Bleeding